IGENE Biotechnology, Inc. (IGNE)

[xZx]

you haven't mentioned the insider bios yet, so i will. check this out:

thomas l. kempner owns 543M shares, according to the filings.

this is his firm:

http://www.loebpartners.com/our_team.html

thomas is getting on in years, but as far as i know he's still active, and he's got two sons who followed in his footsteps, thomas jr and james.

https://www.bloomberg.com/research/stocks/private/person.asp?personId=248423&privcapId=4662676

http://lshpartners.com/dt_team/james-kempner/

michael g. kimelman, about 147M shares:

https://www.bloomberg.com/research/stocks/private/person.asp?personId=279152&privcapId=26841606&previousCapId=26841606&previousTitle=Kimelman%20&%20Baird,%20LLC

sheila m. baird, about 113M shares:

https://www.bloomberg.com/research/stocks/private/person.asp?personId=27483657&privcapId=26841606

i think all of these people, since they don't deal in penny stocks, have the ability to do a big-board level reverse merger here, or maybe they reinstated IGNE to grow the original biotech business via acquisitions.

they have plenty of common stock. that's all the incentive they need.



sheila m baird and canaccord genuity aren't on the list in that screenshot. so the float is even more locked up. all the info is here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140562648